Results of this study had shown a significantly higher than Keywords: glutathione S transferase theta 1; myelodysplastic synexpected incidence of MDS in smokers or ex-smokers, in job drome; karyotype exposure to chemicals in general and in persons exposed to exhaust gases, aromatic hydrocarbons, weed killers and pesticides.
Introduction
Myelodysplastic syndromes (MDS) are clonal disorders of Methods bone marrow stem cells characterized by ineffective hematoFor detecting the presence or absence of GSTT 1 gene in genpoiesis leading to blood cytopenias, and which constitute the omic DNA, we used a multiplex PCR method with primers most frequent of preleukemic states.
1 Their etiology is for GSTT 1 gene 5 and primers for the amplification of a control unknown in the majority of cases but some carcinogens, gene, human coagulation factor V ( Figure 1 ). The incidence including alkylating agents and benzene and its derivatives have been clearly incriminated in the pathogenesis of some cases of MDS.
2,3
It has been suggested that people with reduced ability to metabolize carcinogens are at increased risk of cancer. Conjugation of electrophilic compounds to glutathione S transferase (GST) is an important metabolic pathway for mutagens and carcinogens. 4 GST genes are polymorphic in human beings. Recently, a study found an increased incidence of inherited homozygous deletion of the gene coding for one GST -the GST theta 1 (GSTT 1 gene) -in MDS, by comparison to controls. 5 This finding suggested that the inherited absence of of GSTT 1 null genotype in MDS was compared to that of a 86 cases (Table 2) . No significant differences in the incidence of GSTT 1 null genotype were found between smokers and control population of blood donors with a similar (but not matched) age and sex distribution. One hundred controls non-smokers. MDS patients who had occupied non-qualified jobs generally exposed to industrial compounds (group 9 of were studied.
In the 86 de novo MDS patients included in the case-conthe International Labour Office classification of jobs) had a significantly lower incidence of GSTT 1 genotype (4%) than trol epidemiological study, occupational and environmental exposures were assessed using a questionnaire that included other MDS cases (30%) (P = 0.01). There was a trend for lower incidence of GSTT 1 null genotype in MDS patients who had previous jobs occupied, exposure and level of exposure to a list of 70 compounds, as previously published. [6] [7] [8] [9] [10] previously been coal miners (0 of 12 cases) as compared to other MDS patients (26%, P = 0.06), and in MDS patients Comparisons were made using 2 test and Fisher's exact test.
exposed to any of the 70 substances analyzed (18%), as compared to non-exposed MDS cases (40%, P = 0.08). Nonexposed MDS cases tended to have a higher incidence of GSTT 1 null genotype (40%) than controls (19%, P = 0.07).
Results
A significantly lower incidence of GSTT 1 null genotype was seen in MDS patients exposed to mineral dusts (P = 0.02) and Incidence of GSTT 1 null genotype in MDS patients and in controls exhaust gases (P = 0.03). No differences were seen for other chemicals (data not shown). GSTT 1 null genotype was seen in 39 cases of MDS (22%) as compared to 19 controls (19%) (P = 0.53). As seen in Table 1 Table 1 , no significant differsex and age distribution, and all patients and controls originated from northern France. ences in the incidence of GSTT 1 null genotype were seen according to karyotype, although the number of patients in
We also found no differences of GSTT 1 null genotype each group was relatively small for definite conclusions.
The incidence of GSTT 1 null genotype was 31% in the 16 genotype than MDS patients not exposed to these compounds. ted with lower incidence of GSTT 1 genotype.
